
New data from pivotal studies with aflibercept 8 mg
New data from pivotal studies with aflibercept 8 mg New Subgroup and further analyses from PULSAR, PHOTON and CANDELA provide insights into durability results of extended treatment intervals, patient characteristics as well as efficacy and safety of intravitreal aflibercept 8…



